paclitaxel has been researched along with Hemangioma Thrombocytopenia Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grellety, T; Italiano, A | 1 |
| Fukao, T; Funato, M; Hirose, Y; Hori, T; Kanda, K; Kaneko, H; Kondo, N; Mizuta, K; Ozeki, M; Sasai, H; Terazawa, D | 1 |
1 review(s) available for paclitaxel and Hemangioma Thrombocytopenia Syndrome
| Article | Year |
|---|---|
Paclitaxel-based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature.
Topics: Antineoplastic Agents, Phytogenic; Child; Head and Neck Neoplasms; Hemangioendothelioma; Humans; Kasabach-Merritt Syndrome; Lung Neoplasms; Male; Paclitaxel; Sarcoma, Kaposi | 2013 |
1 other study(ies) available for paclitaxel and Hemangioma Thrombocytopenia Syndrome
| Article | Year |
|---|---|
Angiosarcoma associated with a Kasabach-Merritt syndrome: report of two cases treated with paclitaxel.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Female; Hemangiosarcoma; Humans; Kasabach-Merritt Syndrome; Male; Paclitaxel; Prognosis | 2013 |